Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.120 +0.050 (+1.23%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

Applied Digital And Riot Platforms Are Among Top 10 Mid-Cap Gainers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio? ↗

June 08, 2025

Via Benzinga

Recursion Pharmaceuticals Stock Surges On Breakthrough AI Model Launch With MIT ↗

June 06, 2025

Shares of Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) are trading higher after the company, in collaboration with MIT, announced the release of Boltz-2, a new open-source AI model designed to predict...

Via Benzinga

Topics Artificial Intelligence

MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy

June 06, 2025

From Recursion Pharmaceuticals

Via GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

May 30, 2025

From Recursion Pharmaceuticals

Via GlobeNewswire

Earnings Scheduled For May 5, 2025 ↗

May 05, 2025

Via Benzinga

3 Monster Stocks to Hold for the Next 10 Years ↗

May 26, 2025

A handful of industries are on the verge of explosive growth. These three companies are poised to gain the most.

Via The Motley Fool

Topics Energy

8 Health Care Stocks With Whale Alerts In Today's Session ↗

May 23, 2025

Via Benzinga

These Are the Only 6 Stock Stocks in NVIDIA's 13F Portfolio

May 22, 2025

While institutional money managers have released their Q1 holdings, so has the heart and soul of the AI revolution, NVIDIA. See which six stocks NVIDIA owns.

Via MarketBeat

Topics Artificial Intelligence Earnings

Should You Buy This Beaten-Down Artificial Intelligence (AI) Stock on the Dip? ↗

May 12, 2025

Via The Motley Fool

Topics Animal Testing Artificial Intelligence

2 Top Artificial Intelligence (AI) Stocks to Buy Right Now ↗

May 11, 2025

Via The Motley Fool

Topics Artificial Intelligence

Why Recursion Pharmaceuticals Stock Plummeted 24% This Week ↗

May 09, 2025

Via The Motley Fool

Topics Artificial Intelligence Government Stocks

Why Recursion Pharmaceuticals Stock Is Plummeting Today ↗

May 06, 2025

Via The Motley Fool

Topics Artificial Intelligence Government Stocks

Recursion to Participate in Upcoming Investor Conferences

May 06, 2025

From Recursion Pharmaceuticals

Via GlobeNewswire

Why Recursion Pharmaceuticals Stock Was Getting Mashed on Monday ↗

May 05, 2025

Via The Motley Fool

Topics Artificial Intelligence

Recursion Reports First Quarter 2025 Financial Results and Provides Business Update

May 05, 2025

From Recursion Pharmaceuticals

Via GlobeNewswire

Retail Traders Bearish On Recursion Pharma Ahead of Q1 Results Despite Positive Tupelo Trial Data ↗

May 04, 2025

Traders flagged a key technical level at $4.65 and raised concerns over an outlier patient in the Tupelo trial, with attention now turning to management’s commentary during the earnings call.

Via Stocktwits

Topics Earnings

Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden

May 04, 2025

From Recursion Pharmaceuticals, Inc.

Via GlobeNewswire

How Do Investors Really Feel About Recursion Pharmaceuticals? ↗

May 01, 2025

Via Benzinga

Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth

April 29, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:TEM),(NASDAQ:POAI),(NASDAQ:ADMA) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth

April 29, 2025

From FN Media Group LLC

Via GlobeNewswire

Recursion to Report First Quarter 2025 Business Updates and Financial Results on May 5th

April 28, 2025

Company to host public (L)earnings call on May 5th at 8:00 am ET / 6:00 am MT / 1:00 pm GMT

From Recursion Pharmaceuticals

Via GlobeNewswire

3 Monster Stocks to Hold for the Next 10 Years ↗

April 23, 2025

They're not just leaders of their industry. Their underlying businesses are also on the verge of enormous growth.

Via The Motley Fool

Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025

April 22, 2025

From Recursion Pharmaceuticals

Via GlobeNewswire

This Beaten-Down Artificial Intelligence (AI) Stock Just Got Some Great News: Time to Buy? ↗

April 18, 2025

Via The Motley Fool

Topics Animal Testing Artificial Intelligence Intellectual Property

Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News ↗

April 15, 2025

Via Stocktwits

Topics Animal Testing Artificial Intelligence Stocks

Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing ↗

April 14, 2025

FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

Via Benzinga

Topics Animal Testing

Top 3 Biotech Stocks That Got Retail Street Buzzing Last Week: SMMT, PTN, RXRX ↗

April 13, 2025

Positive expectations from key clinical trials, delisting fears and some regulatory changes triggered a flurry of discussions on Stocktwits for these tickers for the week ended April 11, 2025.

Via Stocktwits

Topics Animal Testing

These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio? ↗

April 13, 2025

Top mid-cap stock performers last week: AGL, RXRX, CERT, AVAV, STRL, ORLA, IAG, SBSW, LOAR, RYTM, TLX. High gains due to positive news and macro uncertainty.

Via Benzinga

The market is filled with gapping stocks in Friday's session. ↗

April 11, 2025

Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Why Recursion Pharmaceuticals Stock Is Skyrocketing Today ↗

April 11, 2025

Via The Motley Fool

Topics Animal Testing Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.